New Orleans Bioinnovation Center

New Orleans BioInnovation Center, Inc.

www.neworleansbio.com

Aaron Miscenich, President

• $48 million LEED Gold Facility

• Formed under 2002 Legislation

• Part of a statewide network

(Shreveport, Baton Rouge, New Orleans)

• LSUHSC/Tulane Partnership, with focus on all New Orleans-based universities

• Funded by LA Department of Economic Development & DoC/EDA

Mission Statement

The mission of the New Orleans BioInnovation Center is to provide support and guidance to companies commercializing biotechnologies in the Greater New Orleans Area by facilitating communications and promoting entrepreneurial thinking.

Canal Street Streetcar Line

REGIONAL & COMMUNITY DESIGN

TYPICAL LAB FLOOR PLAN

Key Ingredients

• Research/Technology

• Experienced Management

• Capital

Areas of Research Expertise

• Infectious Diseases

• Cardiovascular Disease/Hypertension

• Cancer Research & Treatments

• Neurosciences

• Obesity & Diabetes

Areas of Research Expertise

• Biomedical Engineering

• Chemical Engineering

• Vaccines

• Peptides

• Drug Delivery

Attract Management Expertise

• National Recognition

• University Turnover/Recruitment

• Capital Sources

• Expatriates

• Fine Print Factor

Capital Sources

• Grant Opportunities - SBIR/STTR

• Economic Incentives

• Angel Investor

• R&D

• Quality Jobs

• Tech Commercialization & Jobs

Capital Sources

• Partner Capital

• VC/Angel Capital

Capital SourcesProgramming

• Partnerships

• Operations CEA

• BoR Grants

• Innovation Loan & Technical Assistance

• Delta Recovery Authority

• EDA (with GNO, Inc.

• Inventor Interviews (academic researchers, private entrepreneurs)

• Market Analyses

• Patent Searches

• Business Plan Creation

Programming

• Financing Strategies

• Pitch Presentation Preparation

• SBIR/STTR Grant Application Support

• Economic Incentives

Programming

• Seminars, Webinars, Workshops

• Identifying sources of capital (SBIR/STTR grants, Angel, VC)

• Understanding Intellectual Property, Patent Law Reform, Tax Credits

• Round-Table Discussions

• Networking Events/Conferences

• Perkin Mentors

Programming

Results

Total Technologies Actively Supported:

50

Entrepreneurs Interviewed: 71

SBIR/STTR Phase 0 Applications 8

SBIR/STTR Phase I/II Applications 15 (28)

SBIR/STTR Phase I Funded5

~ $2.3 million

Equity-based funding$14

million

NuMe Health is developing evidence-based prebiotic products designed to alter bacterial populations in the GI tract to prevent and manage serious health conditions. NuMe's initial products and research are focusing on pre-diabetes, diabetes and unhealthy body weight.

Innogenomics is a genomics solution provider focused on developing and marketing next-generation genetic testing solutions for paternity and forensic applications. InnoGenomics has secured a strong IP position related to their platform technology and is currently in a research and development phase to optimize a forensic DNA testing kit that will facilitate the use of biological samples that are substantially smaller and/or more degraded than the current industry standard to analyze crime scene evidence.

MiniVax is currently developing therapeutic and preventative vaccines for Pneumocystis carinii, a fungal pathogen that can cause severe, and often fatal, lung infections especially in patients with HIV or other conditions affecting the immune system. MiniVax was recently awarded a $600,000 advanced technologies STTR research and development grant by the NIH.

NanoFex has developed novel nanoparticle technology that provides an affordable, effective method for remediating common, yet extremely dangerous, pollutants in groundwater.

Bioceptive is a medical device startup built on a patent-pending intrauterine device (IUD) inserter that minimizes complications associated with currently used inserters and insertion techniques. Bioceptive has recently taken on pre-seed funding through two independent outside investment groups in order to fund further prototype validation studies.

VoiceHIT is a web-based platform that uses predictive modeling and 3rd-party applications and devices to leverage the power of data to prompt action, facilitate collaboration, and proactively manage health. This creates a seamless platform that extends to 3rd-party applications and mobile health devices, breaks down silos, and integrates data in order to proactively prompt action by providers and patients alike. The Better DayTM platform facilitates 100% patient focus, saving time and improving care.

Wibi+Works is developing methods to improve the anti-inflammatory properties of stem-cells for use in a variety of disease states, including rheumatoid arthritis. The ability to create uniform cellular therapeutics with predictable behavior is anticipated to significantly augment the efficacy of mesenchymal stem-cell therapeutics addressing inflammation-related disorders.

ReactWell is a next-generation oil company developing technology to produce high-volume biomass-based crude oil and various other valuable commodities. Our technology bridges proven geothermal technology, aquaculture and biofuels. ReactWell transforms waste and biomass into clean, sustainable, and cost-effective synthetic crude oil. This unique technology is internationally patent-pending.

Technology Start-Up Success

Community

56 Employees

Start-UpsCapital Companies

CROConsultants

Community

Law FirmsVC/Angels

Professional ServicesBusiness Support Services

Business Partners

Challenges

• Continued Development of an Entrepreneurial Culture

• Maintaining and Growing Current Research Base

• Workforce / Experienced Management

• Retaining Incubator Graduates

• Capital

Near Term Strategy

• Expand Reach into Business Community

• Increased National Coverage of Mission, Clients, Partners

• Attract National/International Partners

• Expand Programming

• Form Advisory Committee

• Establish Graduation Facility

New Orleans BioInnovation Center, Inc.

www.neworleansbio.com